Cell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification

Similar documents
Pharmacology Week 6 ANTIMICROBIAL AGENTS

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Other Beta - lactam Antibiotics

2015 Antibiotic Susceptibility Report

2016 Antibiotic Susceptibility Report

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

Approach to pediatric Antibiotics

Beta-lactams 1 รศ. พญ. มาล ยา มโนรถ ภาคว ชาเภส ชว ทยา. Beta-Lactam Antibiotics. 1. Penicillins 2. Cephalosporins 3. Monobactams 4.

ß-lactams. Sub-families. Penicillins. Cephalosporins. Monobactams. Carbapenems

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.

Antibiotics Affecting the Bacterial Cell Wall

Antibiotics 1. Lecture 8

Antimicrobial drugs Antimicrobial drugs

number Done by Corrected by Doctor Dr.Malik

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

Antimicrobials. Antimicrobials

** the doctor start the lecture with revising some information from the last one:

Microbiology ( Bacteriology) sheet # 7

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Beta-lactam antibiotics - Cephalosporins

Appropriate Antimicrobial Therapy for Treatment of

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

10/15/08. Activity of an Antibiotic. Affinity for target. Permeability properties (ability to get to the target)

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

GENERAL NOTES: 2016 site of infection type of organism location of the patient

RESISTANCE TO ANTIBIOTICS. A. Some scary statistics. B. Nature of genotypic alterations drug resistance

January 2014 Vol. 34 No. 1

CONTAGIOUS COMMENTS Department of Epidemiology

Antimicrobial Therapy

Introduction to antimicrobial agents

Antimicrobial Susceptibility Testing: Advanced Course

number Done by Corrected by Doctor

chapter 15 microbial mechanisms of pathogenicity

Penicillins, cephalosporins, carbapenems monobactams

Antibiotics (2): - Before you start: this lecture has a lot of names and things get entangled together, but I

PHAMACOLOGY 2 nd EXAM QUESTIONS 2012/2013

Protein Synthesis Inhibitors

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

Introduction to Antimicrobials. Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail.

Advanced Practice Education Associates. Antibiotics

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Mechanism of antibiotic resistance

Concise Antibiogram Toolkit Background

num Doctor Done by Corrected by Maha AbuAjamieh Lara Abdallat Dr. Malik

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Amoxicillin Introduction: Mechanism of action: Pharmacology: Indications: Dosage: 12 Weeks ( 3 Months):

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Antibiotic Updates: Part II

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

January 2014 Vol. 34 No. 1

56 Clinical and Laboratory Standards Institute. All rights reserved.

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Antimicrobial Susceptibility Testing: The Basics

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

D4/D5 The Miracle Drug

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

Introduction to Pharmacokinetics and Pharmacodynamics

Amoxicillin clavulanic acid spectrum

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

CONTAGIOUS COMMENTS Department of Epidemiology

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

EUCAST recommended strains for internal quality control

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

What s new in EUCAST methods?

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

CONTAGIOUS COMMENTS Department of Epidemiology

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Antimicrobial Resistance and Prescribing

SUMMARY OF PRODUCT CHARACTERISTICS

Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Antibiotics. Sulfonamides, Penicillins, Cephalosporins, Tetracyclines, Floroquinolones, Aminoglycosides and other Anti-infectives

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Intravenous Antibiotic Therapy Information Leaflet

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Unasyn alternative if penicillin allergic

Considerations in antimicrobial prescribing Perspective: drug resistance

European Committee on Antimicrobial Susceptibility Testing

B. PACKAGE LEAFLET 1

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

Disclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Antimicrobials & Resistance

Appropriate antimicrobial therapy in HAP: What does this mean?

Principles of Antimicrobial therapy

Antimicrobial susceptibility

Rational management of community acquired infections

Antimicrobial Resistance

Transcription:

Cell Wall Weakeners Antimicrobials: Drugs that Weaken the Cell Wall Beta Lactams Penicillins Cephalosporins Carbapenems Aztreonam Vancomycin Teicoplanin Bacterial Cell Wall Bacterial cytoplasm is hypertonic Tendency to swell and lyse Cell wall is a rigid layer outside the membrane that prevents swelling Basic structure: Peptidoglycan polymer chains Crossbridges hold chains together Transpeptidases: bacterial enzymes needed for cell wall synthesis Autolysins: enzymes that break down the cell wall Penicillin: Basic Method of Action Penicillin Binding Proteins (PBPs): Penicillin targets: located on membrane Inhibits transpeptidases: weakened, abnormal cell wall Prevents inhibition of autolysins: destruction of cell wall To work, PCNs must Penetrate cell wall Bind to PBP Bacterial Resistance to PCNs Inability of PCN to reach PBP (i.e. inability to penetrate the cell wall, esp gram neg) Inactivation of PCN by enzymes (penicillinases and beta-lactamases) Genes for pencillinases are located on both chromosomes and plasmids Less common mechanism of resistance to PCN: alteration of PBP structure PCN Classification Most common classification is by spectrum Narrow spectrum Penicillinase vulnerable Penicillinase resistant (anti-staphylococcal) Broad spectrum Extended spectrum

Prototypical PCN Pencillin G: first discovered Bacteriocidal to gram + and some gram Narrow spectrum Penicillinase senstitive (vulnerable) Uses: Pneumonia and meningitis (strep pneumo) Strep pyogenes (strep throat, scarlet fever, endocarditis, flesh eating bacteria) Syphillis (Treponema pallidium) PCN G: Pharmacokinetics Availability as salts: potassium, procaine, benzathine Absorption PO: no can do; inactivated by gastric acid IM: potassium salt is rapidly absorbed; procaine and benzathine last up to a month but cause low blood levels IV: only potassium salt can be given IV PCN G: Pharmacokinetics Distribution Most tissues Crosses joints, eys, and BBB only with inflammation, e.g. meningitis Elimination Through kidneys Adjust dose in renal insufficiency or failure Side effects and Toxicity Least toxic of all antibiotics Most side effects are caused by salt Potassium may cause dysrhythmias Procaine may cause bizarre behavior Allergic reaction is the major concern 1% 10% of population is allergic Mild to life threatening reactions Prior exposure is needed; *occurs naturally Medic alert bracelet PCN Allergy 5% - 10% of PCN allergy is cross-reactive Allergy is not to PCN itself, but to breakdown products Types Immediate: 2 30 minutes Accelerated: 1 72 hours Late: days to weeks Anaphylaxis is possible (0.02%) Treatment of Patients with PCN Allergy Verify reaction Avoid PCN Mild reactions: cephalosporins may be tried (5% - 10% cross reactivity) Severe reactions: use vancomycin or macrolide If no other alternative, desensitization may be tried. Administer with anthistamines; epinephrine on hand PRN

PCN Interactions Aminoglycosides: inactivates if mixed in same IV solution with PCN Probenecid causes PCN retention in kidneys Bacteriostatic antibiotics decrease efficacy of PCN Other narrow Spectrum PCN Penicillin V (aka VK) Same as Penicillin G, but can be given orally May be taken with meals Narrow Spectrum Penicillinase Resistant PCNs Used for staphylococcus 90% of staph produces penicillinase MRSA: resistance by altering PBPs Nafcillin, Oxacillin, Cloxacillin, Dicloxacillin Methicillin (no longer available in U.S.) Broad spectrum Penicillins (aka Aminopenicillins) Same action as Penicillin G plus increased activity against gram-negative bacilli H. influenzae, E. coli, Salmonella, Shigella Penetrate cell wall better Vulnerable to Penicillinase Ampicillin Amoxicillin (most popular penicillin) Bacampacillin Extended Spectrum PCNs Activity includes Aminopenicillins plus: Pseudomonus, Enterobacter, Proteus, Klebsiella Vulnerable to penicillinase Primarily used for Pseudomas aeruginosa, often in combo with aminoglycosides (don t mix!) Ticarcillin, Carbenicillin indanyl, Mezlocillin, Piperacillin PCN/beta-lactamse inhibitor Combos Enhances action of PCN against penicillinase producing bacteria Unasyn: Ampicllin + sulbactam Augmentin: Amoxicillin + clavulanic acid Timentin: Ticarcillin + clavulanic acid Zosyn: Piperacillin + tazobactam

Cephalosporins Beta-lactam antibiotics Similar in action to PCN More resistant to Beta-lactamases Broad spectrum Low toxicity Mechanism of action Same as penicillin Resistance: usually beta-lactamase Cephalosporin Classifications Four Generations: as progress: Increased gram negative activity Decrease gram positive activity Increased resistance to beta-lactamases Increased ability to cross BBB See table 81-2 on page 899 Only one drug currently in fourth generation Cephalosporin Pharmacokinetics 24 Cephalosporins in U.S. 12 can be given PO 2 can be given PO as well as IM/IV Some can be given PO, and some IM/IV Distribution: high to most areas; CSF is not reached with generations 1 and 2. Elimination: kidney; renal dosing in failure Exception: Ceftriaxone and cefoperazone hepatic elimination Adverse Effects Allergic reactions: maculopapular rash after 2 3 days is most common; severe immediate reaction is rare Cross reactivity with PCN Bleeding: cefmetazole, cefoperazone, cefotetan can interfere with Vit K metabolism Thromboplebitis: dilute and infuse slowly to avoid Cephalosporins: Interactions Probenecid: delays renal excretion Alcohol: three drugs that interfere with Vit K metabolism may induce ETOH intolerance Anti-coagulants Cephalosporins: Uses 1 st and 2 nd Generation are usually used prophylactically in hospital, not for active infections 3 rd Generation used for a variety of infections Meningitis, Pneumonia, Nosocomial infections Ceftriaxone especially popular in ER because it can be given one dose IM 4 th Generation is still being established

Cephalosporin use 24 to choose from; how do you choose? Cost, dosing schedule, patient setting Recognize: Cephalexin Cefazolin Cefuroxime Cefaclor Ceftriaxone Ceftazidime Cefepime Carbapenems Beta-lactam antibiotics with broadest spectrum; IV or IM only Used for mixed infections with anarobes, staph, and gram-negative bacilli Imipenem (given with cilastin to prolong effects) Meropenem Ertapenem Monobactam (a class of one) Aztreonam Beta-lactam antibiotic Narrow spectrum: only gram negative bacilli Highly resistant to beta-lactamase Vancomycin (A drug without class) Does not contain beta-lactam Used for: MRSA Pseudomembranous colitis (c. diff) Poor PO absorption: used for c. diff Usually given IV. Low therapeutic range Potentially toxic: ototoxic, thrombophlebitis, nephrotoxicic Must monitor levels Infuse over 60 minutes to avoid histamine reaction Teicoplanin Investigational drug A better vancomycin? Active against MRSA Fewer side effects IM injection possible Therapeutic niche has not yet been established